Press release - 13/08/2026 PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/prame-specific-t-cell-therapy-adolescent-metastatic-kidney-tumor
Press release - 18/08/2026 A local barrier against respiratory viruses How can a respiratory virus be stopped before it spreads throughout the body? In the MucoShield project, Prime Vector Technologies, the NMI Tübingen, and Fraunhofer IGB are developing an intranasal vaccine candidate against human metapneumovirus (HMPV), which causes hundreds of thousands of cases of severe respiratory disease worldwide each year – especially among children, older people, and immunocompromised individuals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/local-barrier-against-respiratory-viruses
Funding FaBI Dissertation Prize for outstanding dissertations in the field of bioinformatics Competition, Funded by: Bioinformatics Research Group (FaBI), sb_search.searchresult.label.programSubmissionDate: 15/05/2027 https://www.gesundheitsindustrie-bw.de/en/database/funding/fabi-dissertation-prize-outstanding-dissertations-field-bioinformatics
Funding FaBI Dissertation Prize for outstanding dissertations in the field of bioinformatics Competition, Funded by: Bioinformatics Research Group (FaBI), sb_search.searchresult.label.programSubmissionDate: 15/05/2027 https://www.bio-pro.de/en/service/funding/fabi-dissertation-prize-outstanding-dissertations-field-bioinformatics
Event - 01/10/2026 Swiss Nordic Bio 2026 Zurich, Switzerland, Registration deadline: 30/09/2026, Conference https://www.gesundheitsindustrie-bw.de/en/event/swiss-nordic-bio-2026-en
Funding Quick-Check and Legal Quick-Check for AI-Applications Funding programme, Funded by: State of Baden-Württemberg, sb_search.searchresult.label.programSubmissionDate: 20/10/2026 https://www.bio-pro.de/en/service/funding/quick-check-and-legal-quick-check-ai-applications
Funding Wittenstein Biointelligence Award Competition, Funded by: Wittenstein Foundation, sb_search.searchresult.label.programSubmissionDate: 13/08/2028 https://www.gesundheitsindustrie-bw.de/en/database/funding/wittenstein-biointelligence-award-en
Funding Wittenstein Biointelligence Award Competition, Funded by: Wittenstein Foundation, sb_search.searchresult.label.programSubmissionDate: 13/08/2028 https://www.bio-pro.de/en/service/funding/wittenstein-biointelligence-award-en
Funding 4C Accelerator Funding programme, Funded by: Baden-Württemberg Ministry of Economics, Labor and Tourism and its Startup BW campaign, the B. Braun Stiftung, and the Hector Stiftung, sb_search.searchresult.label.programSubmissionDate: 03/08/2027 https://www.gesundheitsindustrie-bw.de/en/database/funding/4c-accelerator
Funding 4C Accelerator Funding programme, Funded by: Baden-Württemberg Ministry of Economics, Labor and Tourism and its Startup BW campaign, the B. Braun Stiftung, and the Hector Stiftung, sb_search.searchresult.label.programSubmissionDate: 03/08/2027 https://www.bio-pro.de/en/service/funding/4c-accelerator
Funding Next Frontier Robotics Competition, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 22/10/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/next-frontier-robotics-en
Funding Next Frontier Robotics Competition, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 22/10/2026 https://www.bio-pro.de/en/service/funding/next-frontier-robotics-en
Event - 27/11/2026 Targeted Drug Delivery Ulm, Registration deadline: 20/11/2026, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/targeted-drug-delivery-en
Panosome GmbH – a parasite as the basis for innovative immunotherapies - 26/08/2026 Reaching the unreachable: new approaches to challenging drug targets Modern medicines act with remarkable precision. Antibodies, for example, recognise their molecular targets much like a key fits into its corresponding lock. However, certain targets like small molecules or carbohydrates remain difficult to target. The start-up Panosome aims to eliminate these blind spots with a novel immunotherapy platform that harnesses sophisticated masters of immune evasion: trypanosomes.https://www.gesundheitsindustrie-bw.de/en/article/news/reaching-unreachable-new-approaches-challenging-drug-targets
Funding Recoding Medicine Competition, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 16/10/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/recoding-medicine-en
Funding Recoding Medicine Competition, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 16/10/2026 https://www.bio-pro.de/en/service/funding/recoding-medicine-en
Exploit opportunities, mastering challenges Post-Brexit https://www.bio-pro.de/en/projects/Completed-projects/post-brexit
Press release - 25/08/2026 Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease Revier Therapeutics, today announced the closing of a EUR 6 million seed financing and the launch of its operations. The Company has established the first therapeutic approach to selectively target class IIa histone deacetylases (HDACs) for the treatment of cardiometabolic diseases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/revier-therapeutics-launches-euro-6-million-seed-financing-pioneer-class-iia-hdac-inhibitors-cardiometabolic-disease
Funding FIGHT KIDS CANCER 2026-2027 Competitive Call Funding programme, Funded by: Fight Kids Cancer, sb_search.searchresult.label.programSubmissionDate: 13/10/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/fight-kids-cancer-2026-2027-competitive-call
Funding FIGHT KIDS CANCER 2026-2027 Competitive Call Funding programme, Funded by: Fight Kids Cancer, sb_search.searchresult.label.programSubmissionDate: 13/10/2026 https://www.bio-pro.de/en/service/funding/fight-kids-cancer-2026-2027-competitive-call-en
Medical image analysis - 25/09/2025 Powerful AI systems using synthetic training data AI systems for image analysis are only as good as the data on which they are trained. The Göppingen-based start-up MIRA Vision has developed a novel method for generating synthetic, photorealistic images, enabling the efficient creation of large, high-quality training datasets. An intuitive platform also allows researchers to evaluate microscopy images with ease.https://www.gesundheitsindustrie-bw.de/en/article/news/powerful-ai-systems-image-analysis-using-synthetic-training-data
Start-up Cerebri GmbH - 05/08/2024 Comprehensive EEG supply thanks to telemedicine Fewer and fewer patients are getting timely access to electroencephalograms, as the process of measuring brain activity and interpreting the results requires specific expertise. Cerebri GmbH, a newly established Tübingen-based company, aims to address this issue by offering user-friendly EEG caps and providing rapid, location-independent and top-tier diagnostics by experts.https://www.gesundheitsindustrie-bw.de/en/article/news/comprehensive-eeg-supply-thanks-telemedicine
Robot arm for greater accuracy - 08/06/2022 guidoo: robotic assistance for fast and precise biopsies Needle-based procedures through the skin, such as biopsies of internal organs, not only require a great deal of skill and experience, but they also take time. Fraunhofer IPA Mannheim, together with BEC GmbH from Pfullingen, is developing a robotic surgical assistance system that supports the correct positioning and angulation of a needle with the help of a guide sleeve. This significantly speeds up the procedure while maintaining precision.https://www.gesundheitsindustrie-bw.de/en/article/news/guidoo-robotic-assistance-fast-and-precise-biopsies